Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Predictors of early relapse in patients with non-infectious mixed cryoglobulinemia vasculitis: results from the French nationwide CryoVas survey.

Terrier B, Marie I, Launay D, Lacraz A, Belenotti P, de Saint-Martin L, Quemeneur T, Huart A, Bonnet F, Le Guenno G, Kahn JE, Hinschberger O, Rullier P, Diot E, Lazaro E, Bridoux F, Zénone T, Carrat F, Hermine O, Léger JM, Mariette X, Senet P, Plaisier E, Cacoub P.

Autoimmun Rev. 2014 Jun;13(6):630-4. doi: 10.1016/j.autrev.2013.11.006. Review.

PMID:
24418300
2.

Non HCV-related infectious cryoglobulinemia vasculitis: Results from the French nationwide CryoVas survey and systematic review of the literature.

Terrier B, Marie I, Lacraz A, Belenotti P, Bonnet F, Chiche L, Graffin B, Hot A, Kahn JE, Michel C, Quemeneur T, de Saint-Martin L, Hermine O, Léger JM, Mariette X, Senet P, Plaisier E, Cacoub P.

J Autoimmun. 2015 Dec;65:74-81. doi: 10.1016/j.jaut.2015.08.008. Review.

PMID:
26320984
3.

Non-infectious cryoglobulinemia vasculitis (CryoVas): update on clinical and therapeutic approach.

Perez-Alamino R, Espinoza LR.

Curr Rheumatol Rep. 2014 May;16(5):420. doi: 10.1007/s11926-014-0420-0. Review.

PMID:
24647999
4.

Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey.

Terrier B, Krastinova E, Marie I, Launay D, Lacraz A, Belenotti P, de Saint-Martin L, Quemeneur T, Huart A, Bonnet F, Le Guenno G, Kahn JE, Hinschberger O, Rullier P, Diot E, Lazaro E, Bridoux F, Zénone T, Carrat F, Hermine O, Léger JM, Mariette X, Senet P, Plaisier E, Cacoub P.

Blood. 2012 Jun 21;119(25):5996-6004. doi: 10.1182/blood-2011-12-396028.

5.

Cryoglobulinemia Vasculitis.

Cacoub P, Comarmond C, Domont F, Savey L, Saadoun D.

Am J Med. 2015 Sep;128(9):950-5. doi: 10.1016/j.amjmed.2015.02.017. Review.

PMID:
25837517
6.

Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry.

Terrier B, Launay D, Kaplanski G, Hot A, Larroche C, Cathébras P, Combe B, de Jaureguiberry JP, Meyer O, Schaeverbeke T, Somogyi A, Tricot L, Zénone T, Ravaud P, Gottenberg JE, Mariette X, Cacoub P.

Arthritis Care Res (Hoboken). 2010 Dec;62(12):1787-95. doi: 10.1002/acr.20318.

7.

Cryoglobulinemia vasculitis: an update.

Terrier B, Cacoub P.

Curr Opin Rheumatol. 2013 Jan;25(1):10-8. doi: 10.1097/BOR.0b013e32835b15f7. Review.

PMID:
23196322
8.

The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases.

Terrier B, Karras A, Kahn JE, Le Guenno G, Marie I, Benarous L, Lacraz A, Diot E, Hermine O, de Saint-Martin L, Cathébras P, Leblond V, Modiano P, Léger JM, Mariette X, Senet P, Plaisier E, Saadoun D, Cacoub P.

Medicine (Baltimore). 2013 Mar;92(2):61-8. doi: 10.1097/MD.0b013e318288925c.

9.

Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas survey.

Terrier B, Carrat F, Krastinova E, Marie I, Launay D, Lacraz A, Belenotti P, de Saint Martin L, Quemeneur T, Huart A, Bonnet F, Le Guenno G, Kahn JE, Hinschberger O, Rullier P, Hummel A, Diot E, Pagnoux C, Lzaro E, Bridoux F, Zenone T, Hermine O, Leger JM, Mariette X, Senet P, Plaisier E, Cacoub P.

Ann Rheum Dis. 2013 Mar;72(3):374-80. doi: 10.1136/annrheumdis-2012-201405.

PMID:
22586172
10.

Presentation and prognosis of cardiac involvement in hepatitis C virus-related vasculitis.

Terrier B, Karras A, Cluzel P, Collet JP, Sène D, Saadoun D, Cacoub P.

Am J Cardiol. 2013 Jan 15;111(2):265-72. doi: 10.1016/j.amjcard.2012.09.028.

PMID:
23116612
11.

Using rituximab plus fludarabine and cyclophosphamide as a treatment for refractory mixed cryoglobulinemia associated with lymphoma.

Saadoun D, Pineton de Chambrun M, Hermine O, Karras A, Choquet S, Jego P, Decaux O, Cacoub P.

Arthritis Care Res (Hoboken). 2013 Apr;65(4):643-7. doi: 10.1002/acr.21856.

12.

Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review.

Visentini M, Tinelli C, Colantuono S, Monti M, Ludovisi S, Gragnani L, Mitrevski M, Ranieri J, Fognani E, Piluso A, Granata M, De Silvestri A, Scotti V, Mondelli MU, Zignego AL, Fiorilli M, Casato M.

Autoimmun Rev. 2015 Oct;14(10):889-96. doi: 10.1016/j.autrev.2015.05.013.

PMID:
26031898
13.

Efficacy and safety of long-term treatment with low-dose rituximab for relapsing mixed cryoglobulinemia vasculitis.

Colantuono S, Mitrevski M, Yang B, Tola J, Carlesimo M, De Sanctis GM, Fiorilli M, Casato M, Visentini M.

Clin Rheumatol. 2017 Mar;36(3):617-623. doi: 10.1007/s10067-017-3552-6.

PMID:
28111716
14.

Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis.

Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, Nachman PH.

Ann Intern Med. 2005 Nov 1;143(9):621-31.

PMID:
16263884
15.

Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study.

Quartuccio L, Zuliani F, Corazza L, Scaini P, Zani R, Lenzi M, Tavoni A, Sebastiani M, Baldovino S, Urraro T, Saccardo F, Sbreglia C, Mazzaro C, Pioltelli P, Fraticelli P, Filippini D, Gabrielli A, Perrella O, Scarpato S, Roccatello D, Zignego AL, Ferri C, Bombardieri S, Pietrogrande M, Monti G, Galli M, De Vita S.

J Autoimmun. 2015 Sep;63:88-93. doi: 10.1016/j.jaut.2015.07.012.

PMID:
26255249
16.

Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature.

Ferri C, Cacoub P, Mazzaro C, Roccatello D, Scaini P, Sebastiani M, Tavoni A, Zignego AL, De Vita S.

Autoimmun Rev. 2011 Nov;11(1):48-55. doi: 10.1016/j.autrev.2011.07.005. Review.

PMID:
21821153
18.

Hepatitis C virus-induced vasculitis: therapeutic options.

Cacoub P, Terrier B, Saadoun D.

Ann Rheum Dis. 2014 Jan;73(1):24-30. doi: 10.1136/annrheumdis-2013-203883. Review.

PMID:
23921995
19.

Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand?

Cacoub P, Delluc A, Saadoun D, Landau DA, Sene D.

Ann Rheum Dis. 2008 Mar;67(3):283-7. Review.

20.

Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.

Landau DA, Saadoun D, Halfon P, Martinot-Peignoux M, Marcellin P, Fois E, Cacoub P.

Arthritis Rheum. 2008 Feb;58(2):604-11. doi: 10.1002/art.23305.

Supplemental Content

Support Center